Patrick A. Baeuerle's most recent trade in Cullinan Oncology Inc was a trade of 77,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Patrick A. Baeuerle | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 38,500 | 76,000 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 37,500 | 37,500 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Sale of securities on an exchange or to another person at price $ 28.45 per share. | 08 Sep 2021 | 11,000 | 0 | - | 28.5 | 312,950 | Common Stock |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 11,000 | 240,114 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Sep 2021 | 11,000 | 11,000 | - | 4.3 | 47,300 | Common Stock |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 11,000 | 251,114 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 10 Aug 2021 | 11,000 | 0 | - | 27 | 297,000 | Common Stock |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 10 Aug 2021 | 11,000 | 11,000 | - | 4.3 | 47,300 | Common Stock |
| Cullinan Oncology Inc | Patrick A. Baeuerle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 286,665 | 286,665 | - | - | Stock Option (Right to Buy) |